Loading...
Krystal Biotech, Inc.
KRYS•NASDAQ
Healthcare
Biotechnology
$147.61
$-2.39(-1.59%)
Krystal Biotech, Inc. (KRYS) Financial Performance & Income Statement Overview
Review Krystal Biotech, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
473.02%
↑ 473.02%
Operating Income Growth
159.87%
↑ 159.87%
Net Income Growth
715.58%
↑ 715.58%
Operating Cash Flow Growth
238.98%
↑ 238.98%
Operating Margin
36.30%
↑ 36.30%
Gross Margin
92.61%
↑ 92.61%
Net Profit Margin
37.18%
↑ 37.18%
ROE
13.56%
↑ 13.56%
ROIC
12.17%
↑ 12.17%
Krystal Biotech, Inc. (KRYS) Income Statement & Financial Overview
Review Krystal Biotech, Inc.'s (KRYS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $91.14M | $83.84M | $70.28M | $45.25M |
| Cost of Revenue | $4.95M | $6.68M | $8.00M | $2.42M |
| Gross Profit | $86.19M | $77.16M | $62.29M | $42.83M |
| Gross Profit Ratio | $0.95 | $0.92 | $0.89 | $0.95 |
| R&D Expenses | $13.52M | $13.51M | $15.58M | $10.96M |
| SG&A Expenses | $31.29M | $28.71M | $25.64M | $26.06M |
| Operating Expenses | $44.81M | $54.72M | $41.22M | $37.02M |
| Total Costs & Expenses | $49.76M | $61.41M | $49.22M | $39.43M |
| Interest Income | $0.00 | $0.00 | $7.48M | $7.62M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.59M | $1.53M | $1.99M | $1.61M |
| EBITDA | $42.93M | $31.26M | $18.03M | $2.54M |
| EBITDA Ratio | $0.47 | $0.37 | $0.26 | $0.44 |
| Operating Income | $41.38M | $22.43M | $21.07M | -$6.68M |
| Operating Income Ratio | $0.45 | $0.27 | $0.30 | -$0.15 |
| Other Income/Expenses (Net) | $7.23M | $7.34M | -$5.02M | -$4.88M |
| Income Before Tax | $48.61M | $29.77M | $16.05M | $932000.00 |
| Income Before Tax Ratio | $0.53 | $0.36 | $0.23 | $0.02 |
| Income Tax Expense | $3.13M | $2.59M | $477000.00 | $4.88M |
| Net Income | $45.48M | $27.18M | $15.57M | $932000.00 |
| Net Income Ratio | $0.50 | $0.32 | $0.22 | $0.02 |
| EPS | $1.58 | $0.95 | $0.54 | $0.03 |
| Diluted EPS | $1.52 | $0.91 | $0.53 | $0.03 |
| Weighted Avg Shares Outstanding | $28.75M | $28.72M | $28.60M | $28.30M |
| Weighted Avg Shares Outstanding (Diluted) | $29.88M | $29.90M | $29.64M | $29.29M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan